Skip to main content

Advertisement

SpringerLink
Log in

Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases

  • Research Article
  • Published:
Tumor Biology

Abstract

Cryoablation and surgery achieve similar removal rates for some colorectal cancer (CRC) liver metastasis removal, and systemic chemotherapy is accepted as the most important approach to improving overall survival (OS) in CRC patients with liver metastases. We aimed to evaluate the potential benefit of cryoablation plus chemotherapy in CRC patients with liver metastases. We retrospectively analyze 63 patients of CRC liver metastasis. There were 32 patients in group A, who have received cryoablation plus chemotherapy, and there were 31 patients in group B, who have received chemotherapy alone. We mainly observe the 2-year survival, the quality of life (QOL), and adverse effects. Patients in group A had a higher 2-year survival rate, better OS, better QOL, and better treatment response than patients in group B. Two-year survival rates were 71.9 and 51.6 %,respectively, in group A and group B. The negative conversion rates of carcinoembryonic antigen and carbohydrate antigen 19-9 (CA199) were 57.1 and 61.5 %, respectively, in group A, and 22.2 and 30 %, respectively, in group B. The tumor shrinkage (a tumor volume reduction of ≥30 %) rates were 62.5 and 22.6 %, respectively, in groups A and B. Performance status remained stable or improved in 16 patients (50 %) in group A and eight patients (25.81 %) in group B. Cryoablation in combination with chemotherapy may increase the 2-year survival rate and improve QOL in CRC patients with liver metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

CA19-9:

Carbohydrate antigen 19-9

CEA:

Carcinoembryonic antigen

CRC:

Colorectal cancer

CT:

Computed tomography

MRI:

Magnetic resonance imaging

OS:

Overall survival

QOL:

Quality of life

References

  1. American Cancer Society. Cancer facts & figures 2007. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf (accessed 13 Aug 2008).

  2. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–92.

    Article  CAS  PubMed  Google Scholar 

  3. Sutcliffe RP, Bhattacharya S. Colorectal liver metastases. Br Med Bull. 2011;99:107–24.

    Article  PubMed  Google Scholar 

  4. Stangl R, Altendorf-Hofmann A, Charnley RM, et al. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343:1405–10.

    Article  CAS  PubMed  Google Scholar 

  5. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984;199:502–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Jungraithmayr W, Burger D, Olschewski M, et al. Cryoablation of malignant liver tumors: results of a single center study. Hepatobiliary Pancreat Dis Int. 2005;4:554–60.

    PubMed  Google Scholar 

  7. Kerkar S, Carlin AM, Sohn RL, et al. Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors. Surgery. 2004;136:770–9.

    Article  PubMed  Google Scholar 

  8. Colon and rectal cancer guidelines Version 3. 2014, 01/27/14. National Comprehensive Cancer Network, Inc. 2014.

  9. Alpantaki K, Datsis G, Zoras O, et al: The value of cryosurgery in treating a case of thoracic chondrosarcoma. Case Report Med. 2011:243243.

  10. Seifert JK, Junginger T. Cryotherapy for liver tumors: current status, perspectives, clinical results, and review of literature. Technol Cancer Res Treat. 2004;3:151–63.

    Article  CAS  PubMed  Google Scholar 

  11. Gignoux BM, Ducerf C, Mabrut JY, et al. Cryosurgery of primary and metastatic cancers of the liver. Ann Chir. 2001;126:950–9.

    Article  CAS  PubMed  Google Scholar 

  12. Mala T, Edwin B, Samset E, et al. Magnetic-resonance-guided percutaneous cryoablation of hepatic tumours. Eur J Surg. 2001;167:610–7.

    Article  CAS  PubMed  Google Scholar 

  13. Yoon SS, Tanabe KK. Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist. 1999;4:197–208.

    CAS  PubMed  Google Scholar 

  14. Li Z, Zhang C, Lou C, et al. Comparison of percutaneous cryosurgery and surgical resection for the treatment of small hepatocellular carcinoma. Oncol Lett. 2013;6:239–45.

    PubMed Central  PubMed  Google Scholar 

  15. van der Pool AE, Lalmahomed ZS, de Wilt JH, et al. Trends in treatment for synchronous colorectal liver metastases: differences in outcome before and after 2000. J Surg Oncol. 2010;102:413–8.

    Article  PubMed  Google Scholar 

  16. O J Garden, M Rees, G J Poston, et al: Guidelines for resection of colorectal cancer liver metastases. 2006 August; 55(Suppl 3): iii1–iii8.

  17. Nair RT, Silverman SG, Tuncali K, et al. Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: experience in 48 procedures. Radiology. 2008;248:303–11.

    Article  PubMed  Google Scholar 

  18. Souna BS, Belot N, Duval H, et al. No recurrences in selected patients after curettage with cryotherapy for grade I chondrosarcomas. Clin Orthop Relat Res. 2010;468:1956–62.

    Article  PubMed Central  PubMed  Google Scholar 

  19. O’Reilly DA, Poston GJ. Colorectal liver metastases: current and future perspectives. Future Oncol. 2006;2:525–31.

    Article  PubMed  Google Scholar 

  20. Al-Asfoor A, Fedorowicz Z, Lodge M: Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database Syst Rev. 2008:CD006039.

  21. Hinshaw JL, Lee Jr FT. Cryoablation for liver cancer. Tech Vasc Interv Radiol. 2007;10:47–57.

    Article  PubMed  Google Scholar 

  22. Van Cutsem E, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol. 2001;19:4097–106.

    PubMed  Google Scholar 

  23. Freyer G, Rougier P, Bugat R, et al. Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups. Br J Cancer. 2000;83:431–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938–47.

    PubMed  Google Scholar 

Download references

Acknowledgments

The present study was supported by Heilongjiang Province Foundation for Returness, China (LC2013C28) to Z.L.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Medical Oncology, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, 150081, Heilongjiang Province, People’s Republic of China

    Zhiwei Li, Yujiao Fu, Qingwei Li, Feihu Yan, Juan Zhao & Yanqiao Zhang

  2. Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, The University of Rhode Island, 41 Lower College Road, Kingston, RI, 02881, USA

    Xiaoqun Dong

Authors
  1. Zhiwei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yujiao Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qingwei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Feihu Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaoqun Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yanqiao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yanqiao Zhang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Z., Fu, Y., Li, Q. et al. Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases. Tumor Biol. 35, 10841–10848 (2014). https://doi.org/10.1007/s13277-014-2374-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2374-2

Keywords

Search

Navigation